Phase 3 Trials of Solanezumab and Bapineuzumab for Alzheimer's Disease

Title
Phase 3 Trials of Solanezumab and Bapineuzumab for Alzheimer's Disease
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 370, Issue 15, Pages 1459-1460
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2014-04-10
DOI
10.1056/nejmc1402193

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now